Market Research Logo

Czech Republic Pharmaceuticals & Healthcare Report Q3 2018

Czech Republic Pharmaceuticals & Healthcare Report Q3 2018

BMI View:

The Czech Republic will remain one of the most attractive markets for innovative drugmakers in Central and EasternEurope due to increasing demand for higher-value medicines. We note, however, that a lack of generic medicine uptake posesconsiderable risks to market sustainability, posing downside risks to long-term market growth. Moreover, the market poses feweropportunities for increased FDI by multinational innovative pharmaceutical firms into manufacturing than its regional peers,although investment into clinical trials is likely to remain robust.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Pharmaceuticals Risk/Reward Index
Czech Republic Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Zentiva (Sanofi)
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report